PNC Financial Services Group
SVA

PNC Financial Services Group’s Sinovac Biotech, Ltd SVA Stock Holding History

PNC Financial Services Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,500
Closed -$39K – 4912
2015
Q2 		$39K Hold
7,500
– – ﹤0.01% 3171
2015
Q1 		$37K Buy
+7,500
New +$36.9K ﹤0.01% 3206
2014
Q4 		– Sell
-5,000
Closed -$24K – 4428
2014
Q3 		$24K Hold
5,000
– – ﹤0.01% 3003
2014
Q2 		$28K Buy
+5,000
New +$30.4K ﹤0.01% 2814

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PNC Financial Services Group's SVA Position: Q3 2015 in Review

PNC Financial Services Group sold out of Sinovac Biotech, Ltd (SVA) in Q3 2015, closing a stake of 7,500 shares — an estimated $39K sold.

PNC Financial Services Group first reported a position in SVA in Q2 2014 and held it in 4 quarters. The position peaked at $39K in Q2 2015. 37 funds tracked by Wall St. Rank hold SVA as of Q3 2015.

  • PNC Financial Services Group reported no remaining Sinovac Biotech, Ltd position as of Q3 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 7,500 Sinovac Biotech, Ltd shares in Q3 2015, an estimated $39K.
  • PNC Financial Services Group first reported a position in Sinovac Biotech, Ltd in Q2 2014 and held it in 4 quarters.
  • PNC Financial Services Group's Sinovac Biotech, Ltd position peaked at $39K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2015.

Based on PNC Financial Services Group's 13F filing for Q3 2015, filed 6 Nov 2015.